首页> 外文期刊>Analytical methods >Development of enantiospecific and chemoselective methods for the determination of praeruptorin A enantiomers and their metabolites in rat plasma using chiral and achiral LC-MS/MS
【24h】

Development of enantiospecific and chemoselective methods for the determination of praeruptorin A enantiomers and their metabolites in rat plasma using chiral and achiral LC-MS/MS

机译:建立手性和非手性LC-MS / MS测定大鼠血浆中praeruptorin A对映体及其代谢物的对映体特异性和化学选择性方法

获取原文
           

摘要

Enantioselective pharmacokinetics and metabolism were revealed for (?±)-praeruptorin A (PA), the major bioactive component in Peucedani Radix. In the present study, we deal with the development and validation of two enantioselective methods for enantiospecific determination of PA enantiomers (D-PA/L-PA) and their metabolites, cis-khellactone enantiomers (D-CK/L-CK), rat plasma after intravenous or oral treatment using chiral LC-MS/MS, as well as an achiral LC-MS/MS for simultaneous quantitation of the two hydrolyzed products (L1/L2) after incubation of L-PA in fresh rat plasma. AD-RH and Extend-C18 columns were employed for enantioselective and chemoselective separation, respectively, while the detection was performed on a hybrid triple quadrupole-linear ion trap mass spectrometer with electrospray ionization inlet using a positive selected reaction monitoring mode. The calibration curves of all targeted components showed good linearity (r 0.992) over the respective concentration ranges (D-PA/L-PA: 1.00a€“4830 ng mLa?’1; D-CK/L-CK: 1.50a€“1630 ng mLa?’1; L1/L2: 1.10a€“1080 ng mLa?’1). The lower limits of quantitation for D-PA/L-PA, D-CK/L-CK and L1/L2 were 1.00/1.00, 1.50/1.50 ng mLa?’1 and 1.10/1.10 ng mLa?’1, respectively. For high, medium and low concentration levels of all analytes, the overall intra- and inter-day variations were less than 9.71%, recoveries were in the range 87.7a€“113%, and matrix effects were between 91.1% and 109%. Above all, the chiral and achiral methods that were developed were satisfactory for the determination of D-PA/L-PA, D-CK/L-CK or L1/L2 in rat plasma.
机译:揭示了Peucedani Radix中主要的生物活性成分(?±)-praeruptorin A(PA)的对映选择性药物动力学和新陈代谢。在本研究中,我们处理两种对映体选择性测定PA对映异构体(D-PA / L-PA)及其代谢物顺式-克拉酮对映体(D-CK / L-CK)的开发和验证使用手性LC-MS / MS进行静脉或口服治疗后的血浆,以及用于在新鲜大鼠血浆中孵育L-PA后同时定量两种水解产物(L1 / L2)的非手性LC-MS / MS。 AD-RH和Extend-C18色谱柱分别用于对映选择性和化学选择性分离,而检测是在带有电喷雾电离进样口的混合三重四极杆线性离子阱质谱仪上进行的,采用正选择反应监测模式。所有目标组分的校准曲线在各自的浓度范围内(D-PA / L-PA:1.00a–4830 ng mLa?1; D-CK / L-CK:1.50a)表现出良好的线性(r> 0.992) 1630 ng mLa?1; L1 / L2:1.10a 1080 ng mLa?1)。 D-PA / L-PA,D-CK / L-CK和L1 / L2的定量下限分别为1.00 / 1.00、1.50 / 1.50 ng mLa?-1和1.10 / 1.10 ng mLa?1。对于所有分析物的高,中和低浓度水平,日内和日间总体变化均小于9.71%,回收率在87.7%至113%范围内,基质效应在91.1%至109%之间。最重要的是,开发的手性和非手性方法对于测定大鼠血浆中的D-PA / L-PA,D-CK / L-CK或L1 / L2是令人满意的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号